PNNL researchers Lisa Bramer and Sarah Reehl were on a team that received a patent for its work with electron microscopy. Electron microscopy allows scientists to make nanoscale observations of materials.

A new study focusing on the proteins involved in endometrial cancer, commonly known as uterine cancer, offers insights about which patients will need aggressive treatment and which won’t.

Bill Cannon, senior scientist and biophysicist in the Computational Mathematics Group, was a co-author of a recent article published in Nature Partner Journals-Digital Medicine.

A new book by PNNL biochemist Erick Merkley details forensic proteomics, a technique that directly analyzes proteins in unknown samples, in pursuit of making proteomics a widespread forensic method when DNA is missing or ambiguous.

The researchers treated human pancreatic islets with substances produced by the body and thought to be involved in the diabetes disease process.

While it’s one small step forward for mouse research, it’s a big step forward for understanding proteins, the molecular workhorses in biological organisms.

Researchers at PNNL are contributing artificial intelligence, machine learning, and app development expertise to a U of W project that will ease challenges with urban freight delivery. The project will provide delivery drivers with a tool

A new drug delivery method designed by researchers at PNNL and Washington State University (WSU) has shown it can target and kill lung cancer cells.

In today’s digital age, the rabbit hole of connected information can be not only a time sink, but downright overwhelming. Even for high-performance computers.

Francesca Grogan grew up in Southern California, gravitated to competitive swimming, and chose to stay close to her geographical roots for her undergraduate and postgraduate studies.

The first phase, which started in 2014, generated foundational data from developing mouse and human lungs, created a web portal for public data sharing, and established a repository of human lung tissues.

When two powerful earthquakes rocked southern California earlier this month, officials’ attention focused, understandably, on safety. How many people were injured? Were buildings up to code? How good are we at predicting earthquakes?

Scientists have taken one of the most detailed looks ever at levels of soluble amyloid beta in the brain.

PNNL scientist Wei-Jun Qian and colleagues have contributed to a study that offers clues for delaying or even preventing the autoimmune attack that’s at the core of type-1 diabetes.

PNNL researchers today published a pair of papers, in Cell and in Nature, exploring the effects of the gut microbiome on our health, including autism, brain function, and inflammatory bowel disease.

He is being recognized for his contributions involving various kinds of separations with mass spectrometry (MS).

His patents involve novel MS and IMS technologies that, in the end, have enabled a deeper understanding of living systems.

PNNL researchers have devised a way to measure and distinguish tiny amounts of phosphorylated proteins, an approach that could be used in research to help treat diseases such as diabetes and cancer.

The structure of a fundamental electrical switch in the brain has been revealed, thanks to PNNL researchers working together with counterparts at Oregon Health & Science University (OHSU).

PNNL scientists have taken one of the most in-depth looks ever at the riot of protein activity that underlies colon cancer and have identified potential new molecular targets to try to stop the disease.